Shilpa Medicare’s active pharmaceutical ingredient (API), octreotide, is used in the treatment of conditions such as acromegaly and severe diarrhoea, among others. Shares of Shilpa Medicare Ltd ended at ₹861, down by ₹11.90, or 1.36%, on the BSE.
Shilpa Medicare arm gets European Certificate Of Suitability for diarrhoea molecule
Share it
Related Article
